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LETTER TO THE EDITOR
Patients’, family members’ and
healthcare practitioners’
experiences of Stevens–Johnson
syndrome and toxic epidermal
necrolysis: a qualitative
descriptive study using
emotional touchpoints
Editor
Stevens–Johnson syndrome (SJS) and toxic epidermal necroly-
sis (TEN) are devastating conditions resulting from a severe
immune-mediated mucocutaneous reaction which normally
occurs as a result of medication.1 In the acute phase, the
patient presents with a febrile illness, followed by skin and
mucous membrane necrosis and detachment.2 The patient
can quickly become critically ill and is treated as a medical
emergency. There may be long-lasting psychological effects on
patients and their significant others.3 However, there is a
dearth of research on the experiences of patients with SJS/
TEN, those close to them and healthcare practitioners
(HCPs) providing care.
This study explored key stakeholder experiences of living
with, or caring for, patients with SJS/TEN via a qualitative
descriptive design,4 using emotional touchpoint interviews. A
touchpoint is a moment when an individual interacts in some
way with the health service and an experience is created.5 A pur-
posive sample of patients (n = 2) who had been diagnosed with
SJS/TEN, family members of two other patients (n = 2) and
HCPs (n = 8) who reflected on their experiences of caring for a
number of patients with SJS/TEN, were included in the study.
Participants were presented with a range of emotion words and
were asked how they felt and their perception of how the patient
felt (in the case of family members and HCPs) at different stages
of the illness journey, for example ‘at the beginning’, ‘in hospi-
tal’ and ‘going home’. Additional questions were asked to
expand on their responses. Interview transcripts were analysed
using thematic analysis.6
Three themes with two sub-themes were constructed
(Table 1). The initial presentation of SJS/TEN symptoms was
a frightening and traumatic experience for patients and their
close family members. Patients feared for their lives. For
HCPs, preservation of life was a priority and concerns were
expressed about the importance of ensuring that the patient
received optimum care in the best clinical environment, with
input from the multi-disciplinary team. Meaningful commu-
nication within a caring environment provided patients and
their families with hope and reassurance. Caring behaviours,
such as compassion, dignity, respect, and HCPs ‘just being
there’ for the patient were important for patient recovery.
Patients who survived SJS/TEN, experienced mixed emotions
when going home from hospital. While they were relieved, as
they were alive and well enough to leave hospital, they feared
what may lie ahead. After discharge, their mental health and
quality of life were affected, and they feared taking any medi-
cation.
Healthcare practitioners in our study spoke about the
importance of advocating on behalf of patients to ensure that
they were admitted to the ICU. Valeyrie-Allanore et al.7 high-
lighted that an ICU referral of patients with severe cutaneous
adverse reactions, including SJS/TEN, contributes to improved
patient survival and reduces potential sequelae. Referring to
the need for the long-term follow-up of survivors, Lee and
Creamer8 encourage the inclusion of psychological assessment
in the outpatient follow-up care pathway. They pose the
question on whether psychological interventions during the
acute phase can preclude the occurrence of psychological
problems following discharge.8
Adding to the current body of knowledge, these findings pro-
vide an understanding of how SJS/TEN affects key stakeholders
and informs recommendations to improve patient outcomes
(Table 2). Limitations to the study included the use of one clini-
cal site and a small number of patient participants. There are dif-
ficulties in researching rare conditions, but Walsh et al.9 advise
that this should not deter researchers and HCPs to engage in fol-
low-up discussions with patients to find out more about the psy-
chological consequences of SJS/TEN. Given the psychological
impact on patients’ lives, there is a need to prioritize research in
this area.10
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Table 1 Themes, sub-themes, description and illustrative quotes
Themes Sub-themes Description Illustrative quotes
The profound
impact of
SJS/TEN
Confused, worried
powerless – the mixed
emotions of patients
and families
Strong words were used by all participants to outline the
emotional and physical impact on patients’ lives. One doctor
acknowledged that it is difficult to understand the extent of the
trauma that these patients have experienced.
’Physically in pain and traumatized. He was
disoriented and overwhelmed, he didn’t know
what was happening and he was very frightened’
(Family Member 1)
The challenges
experienced by HCPs
In dermatology, SJS/TEN is one of the most serious
conditions that the team will deal with. Many HCPs may have
never seen or cared for a patient with SJS/TEN. Some
participants spoke about feeling vulnerable. Even with
experience, it is a condition that gives rise to feelings of
anxiousness in HCPs.
’It can be overwhelming because, while I’m quite
comfortable in dealing with skin loss, the patient
can also be systemically very unwell. . .It can be
stressful because you have to instigate care quite
quickly. . . and you’ve to get a team involved like
ophthalmology, ICU. . .’ (Nurse 1)
The care
that matters
Immediacy of
recognition – a
pathway of care
Patients with SJS/TEN deteriorate quickly; they can go from
sitting up and talking to becoming critically ill. The priority of
care, at the beginning, is to keep the patient alive. HCPs
expressed concern that they would make the best case in
convincing others that the patient required admission to the
ICU – not all HCPs appreciated the rapid deterioration of
patients with SJS/TEN. An MDT approach to care was crucial
as the skin is not the only organ that is affected.
’They’re used to admitting someone into the ICU
from a ward but we were saying that he [patient]
was still able to sit and talk but we knew in a
matter of hours he was going to get further
involvement and needed that critical care setting’
(Doctor 3)
Important caring
behaviours
It was important to have a ‘liaison’ person to communicate
with from both an informational and emotional perspective. It
was essential that staff were confident, calm and well
prepared in delivering information and letting the patient know
that they had dealt with similar situations before – to give
patients hope. It was important to recognize that losing the
body’s protective layer of skin increased the patient’s
vulnerability, both physically and psychologically.
’The dermatology staff said it so that you could
understand, it wasn’t technical. They knew what
they were on about, this is their forte’ (Patient 1)
Surviving and
living with the
aftermath
Going home Going home was ‘overwhelming’ for some patients as they
were leaving a secure environment and they were frightened
of getting SJS/TEN again. One patient referred to going home
as ‘daunting’ and scary’. Patients might not always be
prepared for what lay ahead, in that they could experience
profound exhaustion and it could take time to get back to
normal.
’I think just the vulnerability, the going home and
wondering if this happens again, will I go back to
where I was and nobody can tell you that it’s not
going to happen again’ (Nurse 4)
Reality hits After some time at home, reality hit. A family member spoke
about their relative’s anxiety regarding the fear of getting SJS/
TEN again. Patients may have been on a lifesaving
medication and they were often anxious going on a different
medication regime. One patient spoke emphatically about the
great sense of loss that he experienced after getting SJS/
TEN, missing out on education and always playing catch up
with study. He described effects on his relationships and
experiencing social anxiety.
’I didn’t realise the effect it would have on every
aspect, not just my appearance, or my skin, I think
the mental health side of things is important, it has
such a big impact on your life, it’s hard to cope, for
years. . .’ (Patient 2)
HCP, healthcare practitioner; ICU, intensive care unit; MDT, multi-disciplinary team; SJS, Stevens–Johnson syndrome; TEN, toxic epidermal necrolysis.
Table 2 Research summary and recommendations
What is already known about this topic?
• For survivors of SJS/TEN, there may be long-lasting psychological effects on patients and their significant others
• There is a dearth of research on patients’ and other key stakeholders’ experiences of SJS/TEN
What does this study add?
• Preservation of life is the priority for HCPs, and time is of the essence in diagnosing and referring the patient to an intensive care unit.
• Meaningful communication within a caring environment provides patients and their families with hope and reassurance.
• Patients’ mental health and quality of life may be affected in the long term, and they can fear taking medication.
Recommendations to improve patient outcomes
• Caring behaviours such as compassion, dignity, respect and HCPs ‘just being there’ for the patient are important for patient recovery.
• Keeping patients informed at a level that they understand helps to allay fears and distress.
• It is important that all doctors and nurses be made aware of the signs, symptoms and the care needs of patients with SJS/TEN, through continuing educa-
tion and training programmes.
• More research is required to address the psychological impact and care needs of the patient in the acute and follow-up phases of the illness
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